Medication Histories in Critically Ill Patients Completed by Pharmacy Personnel.

administration critical care medication errors medication reconciliation medication safety pharmacist pharmacy technician quality assurance

Journal

The Annals of pharmacotherapy
ISSN: 1542-6270
Titre abrégé: Ann Pharmacother
Pays: United States
ID NLM: 9203131

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 19 1 2019
medline: 31 3 2020
entrez: 19 1 2019
Statut: ppublish

Résumé

Although critically ill adults often have extended hospital lengths of stay and are at high risk of having medication-related adverse events, the value of medication histories in these patients remains underreported. To assess the feasibility of performing medication histories in critically ill adults and to establish the frequency of and characterize identified discrepancies. This prospective study included patients admitted to 4 intensive care units (ICUs) in a large academic medical center and was conducted in 2 phases. In phase 1, medication histories were conducted over a 5-week period by clinical pharmacists to assess feasibility. In phase 2, medication histories were conducted over a 3-week period by a pharmacy technician. Medication discrepancies, defined as any difference between the documented and pharmacy personnel-identified home medication list, were aggregated in both phases and adjudicated for severity. In phase 1, 127 medication histories were completed (42.3% of admitted patients). Impaired cognition was the most common barrier encountered; however, 76% of patients were able to have a history completed if an attempt was made. In phase 2, a medication history was completed for 176 patients (58.9% of admitted patients). In aggregate, 1155 discrepancies were identified, with 78.2% of patients having a discrepancy. The median number of discrepancies per patient was 3 (interquartile range = 1-5); 11 life-threatening, 101 serious, and 326 significant discrepancies were identified. Conclusion and Relevance: A pharmacy personnel-based medication history program in the ICU is feasible and assists in the discovery of medication discrepancies with the potential for patient harm.

Sections du résumé

BACKGROUND
Although critically ill adults often have extended hospital lengths of stay and are at high risk of having medication-related adverse events, the value of medication histories in these patients remains underreported.
OBJECTIVE
To assess the feasibility of performing medication histories in critically ill adults and to establish the frequency of and characterize identified discrepancies.
METHODS
This prospective study included patients admitted to 4 intensive care units (ICUs) in a large academic medical center and was conducted in 2 phases. In phase 1, medication histories were conducted over a 5-week period by clinical pharmacists to assess feasibility. In phase 2, medication histories were conducted over a 3-week period by a pharmacy technician. Medication discrepancies, defined as any difference between the documented and pharmacy personnel-identified home medication list, were aggregated in both phases and adjudicated for severity.
RESULTS
In phase 1, 127 medication histories were completed (42.3% of admitted patients). Impaired cognition was the most common barrier encountered; however, 76% of patients were able to have a history completed if an attempt was made. In phase 2, a medication history was completed for 176 patients (58.9% of admitted patients). In aggregate, 1155 discrepancies were identified, with 78.2% of patients having a discrepancy. The median number of discrepancies per patient was 3 (interquartile range = 1-5); 11 life-threatening, 101 serious, and 326 significant discrepancies were identified. Conclusion and Relevance: A pharmacy personnel-based medication history program in the ICU is feasible and assists in the discovery of medication discrepancies with the potential for patient harm.

Identifiants

pubmed: 30654616
doi: 10.1177/1060028018825483
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

596-602

Auteurs

Bridgette L Kram (BL)

1 Duke University Hospital, Durham, NC, USA.

Morgan A Trammel (MA)

1 Duke University Hospital, Durham, NC, USA.

Shawn J Kram (SJ)

1 Duke University Hospital, Durham, NC, USA.

Sandy E Wheeley (SE)

1 Duke University Hospital, Durham, NC, USA.

Ben G Mancheril (BG)

2 Moses H. Cone Memorial Hospital, Greensboro, NC, USA.

Lindsey D Burgess (LD)

1 Duke University Hospital, Durham, NC, USA.

Jennifer M Schultheis (JM)

1 Duke University Hospital, Durham, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH